Hester Biosciences informs about acquisition

09 Nov 2021 Evaluate

Hester Biosciences has informed that Hester Biosciences (Hester India) has entered into a Shareholder's Agreement, Share Purchase Agreement and Share Subscription Agreement (collectively referred to as Transactional Documents) to: Acquire 486 equity shares of Thrishool Exim Limited (TEL), Tanzania from the existing promoters; and subscribe 1,188 equity shares of TEL. Thereby, acquire and subscribe a total of 1,674 equity shares representing 50% of total issued and paid-up equity share capital of TEL. The background of TEL is mentioned as point number 10 in the Annexure 1. The aforesaid Transaction Agreements are subject to customary conditions precedent and receipt of approvals as listed in Annexure 1 hereto.

The above information is a part of company’s filings submitted to BSE.


Hester Biosciences Share Price

2379.15 1.40 (0.06%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.